Form 4: USANA Health Sciences Director Winssinger Exercises Stock Options

Director Frederic J Winssinger executed a transaction involving restricted stock units of USANA Health Sciences, according to a recent SEC Form 4 filing.

Summary

• On May 2, 2025, Frederic J Winssinger, a director of USANA Health Sciences Inc., executed a transaction involving restricted stock units.
• Winssinger disposed of 674 shares of Common Stock following the vesting of restricted stock units.
• Following the transaction, Winssinger directly owns 5,871 shares of USANA common stock.
• The restricted stock units vest in four tranches: August 2, 2024, November 2, 2024, February 2, 2025, and May 2, 2025.

Sentiment

Score: 5

Explanation: This is a neutral filing, simply reporting a routine transaction. It doesn't inherently indicate positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company directors.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine execution of stock options.

Key Dates

Keywords

USANA Health Sciences, Director, Winssinger, Stock Options, Restricted Stock Units, SEC Form 4, Beneficial Ownership